These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17655277)

  • 21. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
    Tsukamoto K; Smith P; Glick JM; Rader DJ
    J Clin Invest; 1997 Jul; 100(1):107-14. PubMed ID: 9202062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
    Gerritsen G; Kypreos KE; van der Zee A; Teusink B; Zannis VI; Havekes LM; van Dijk KW
    J Lipid Res; 2003 Feb; 44(2):408-14. PubMed ID: 12576523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice.
    Kypreos KE; Zannis VI
    J Lipid Res; 2006 Mar; 47(3):521-9. PubMed ID: 16339113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.
    Chroni A; Koukos G; Duka A; Zannis VI
    Biochemistry; 2007 May; 46(19):5697-708. PubMed ID: 17447731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice.
    Kypreos KE; Morani P; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2001 May; 40(20):6027-35. PubMed ID: 11352738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.
    Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL
    J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE.
    Peng D; Song C; Reardon CA; Liao S; Getz GS
    J Neurochem; 2003 Sep; 86(6):1391-402. PubMed ID: 12950448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels.
    Li H; Dhanasekaran P; Alexander ET; Rader DJ; Phillips MC; Lund-Katz S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):687-93. PubMed ID: 23413428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.
    Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI
    Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice.
    Altenburg M; Arbones-Mainar J; Johnson L; Wilder J; Maeda N
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1104-10. PubMed ID: 18369154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4.
    Nguyen D; Dhanasekaran P; Nickel M; Nakatani R; Saito H; Phillips MC; Lund-Katz S
    Biochemistry; 2010 Dec; 49(51):10881-9. PubMed ID: 21114327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.
    Chroni A; Duka A; Kan HY; Liu T; Zannis VI
    Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
    Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
    Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL.
    Kateifides AK; Gorshkova IN; Duka A; Chroni A; Kardassis D; Zannis VI
    J Lipid Res; 2011 Jul; 52(7):1363-72. PubMed ID: 21504968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.